195 related articles for article (PubMed ID: 20455887)
21. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
22. Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations.
Azizi F; Vagenakis AG; Portnay GI; Rapoport B; Ingbar SH; Braverman LE
N Engl J Med; 1975 Feb; 292(6):273-7. PubMed ID: 803298
[TBL] [Abstract][Full Text] [Related]
23. Laboratory diagnosis of multiple pituitary hormone deficiencies: issues with testing of the growth and thyroid axes.
Nakamoto J
Pediatr Endocrinol Rev; 2009 Jan; 6 Suppl 2():291-7. PubMed ID: 19337184
[TBL] [Abstract][Full Text] [Related]
24. The effect of growth hormone replacement on the thyroid axis in patients with hypopituitarism: in vivo and ex vivo studies.
Glynn N; Kenny H; Quisenberry L; Halsall DJ; Cook P; Kyaw Tun T; McDermott JH; Smith D; Thompson CJ; O'Gorman DJ; Boelen A; Lado-Abeal J; Agha A
Clin Endocrinol (Oxf); 2017 May; 86(5):747-754. PubMed ID: 27809356
[TBL] [Abstract][Full Text] [Related]
25. [Effect of treatment with biosynthetic GH on thyroid function in patients with an isolated deficiency of GH].
Sacco V; Maioli A; Citro G; Galasso R; Vinci ML; Zampino A
Minerva Endocrinol; 1992; 17(1):13-20. PubMed ID: 1495450
[TBL] [Abstract][Full Text] [Related]
26. Central hypothyroidism and growth hormone treatment: clinical care.
Lania A; Giavoli C; Ferrante E; Beck-Peccoz P
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):66-70. PubMed ID: 19020390
[TBL] [Abstract][Full Text] [Related]
27. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
Scaroni C; Ceccato F; Rizzati S; Mantero F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
[TBL] [Abstract][Full Text] [Related]
28. The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy.
Fernández-Pérez L; Nóvoa J; Ståhlberg N; Santana-Farré R; Boronat M; Marrero D; Henríquez-Hernández L; Norstedt G; Flores-Morales A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):800-6. PubMed ID: 19849699
[TBL] [Abstract][Full Text] [Related]
29. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
Wadwekar D; Kabadi UM
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
[TBL] [Abstract][Full Text] [Related]
30. Effects of growth hormone on thyroid function are mediated by type 2 iodothyronine deiodinase in humans.
Yamauchi I; Sakane Y; Yamashita T; Hirota K; Ueda Y; Kanai Y; Yamashita Y; Kondo E; Fujii T; Taura D; Sone M; Yasoda A; Inagaki N
Endocrine; 2018 Feb; 59(2):353-363. PubMed ID: 29274063
[TBL] [Abstract][Full Text] [Related]
31. [Pituitary hyperplasia secondary to primary hypothyroidism in children: report of 8 cases].
Xu AJ; Li T
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan; 12(1):17-20. PubMed ID: 20113627
[TBL] [Abstract][Full Text] [Related]
32. Management of growth hormone deficiency in adults.
Nilsson AG; Svensson J; Johannsson G
Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy.
Rodríguez-Arnao J; Perry L; Besser GM; Ross RJ
Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136
[TBL] [Abstract][Full Text] [Related]
34. Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study.
Curtò L; Giovinazzo S; Alibrandi A; Campennì A; Trimarchi F; Cannavò S; Ruggeri RM
Eur J Endocrinol; 2015 May; 172(5):543-52. PubMed ID: 25646405
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory?
Porretti S; Giavoli C; Ronchi C; Lombardi G; Zaccaria M; Valle D; Arosio M; Beck-Peccoz P
J Clin Endocrinol Metab; 2002 May; 87(5):2042-5. PubMed ID: 11994338
[TBL] [Abstract][Full Text] [Related]
36. Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation.
Wyatt DT; Gesundheit N; Sherman B
J Clin Endocrinol Metab; 1998 Oct; 83(10):3493-7. PubMed ID: 9768652
[TBL] [Abstract][Full Text] [Related]
37. Posterior pituitary functions are not altered after growth hormone replacement therapy in hypopituitarism due to Sheehan's syndrome.
Karaca Z; Tanriverdi F; Atmaca H; Unluhizarci K; Kelestimur F
Growth Horm IGF Res; 2012; 22(3-4):146-9. PubMed ID: 22627149
[TBL] [Abstract][Full Text] [Related]
38. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone.
Lippe BM; Van Herle AJ; LaFranchi SH; Uller RP; Lavin N; Kaplan SA
J Clin Endocrinol Metab; 1975 Apr; 40(4):612-8. PubMed ID: 165211
[TBL] [Abstract][Full Text] [Related]
39. An audit of growth hormone replacement for GH-deficient adults in Scotland.
Philip S; Howat I; Carson M; Booth A; Campbell K; Grant D; Patterson C; Schofield C; Bevan J; Patrick A; Leese G; Connell J
Clin Endocrinol (Oxf); 2013 Apr; 78(4):571-6. PubMed ID: 22901318
[TBL] [Abstract][Full Text] [Related]
40. Low FT4 Concentrations around the Start of Recombinant Human Growth Hormone Treatment: Predictor of Congenital Structural Hypothalamic-Pituitary Abnormalities?
van Iersel L; van Santen HM; Zandwijken GRJ; Zwaveling-Soonawala N; Hokken-Koelega ACS; van Trotsenburg ASP
Horm Res Paediatr; 2018; 89(2):98-107. PubMed ID: 29402813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
